Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127203) titled 'Lisaftoclax in Combination with Daunorubicin and Cytarabine for Newly Diagnosed Acute Myeloid Leukemia: A Prospective, Single-Arm, Phase 2 Clinical Study' on June 26.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Blood Diseases Hospital, Chinese Academy of Medical Sciences

Condition: Acute myeloid leukemia

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-06-30

Target Sample Size: Experimental group:55;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=328804

Published by HT Digital Content Services...